Infants who receive nirsevimab may have a lower risk for hospitalisation for RSV-related lower respiratory tract infection than those protected by maternal RSV vaccination.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/nirsevimab-may-top-maternal-shot-infants-rsv-prevention-2025a10010n2?src=rss
Author :
Publish date : 2026-01-05 12:00:00
Copyright for syndicated content belongs to the linked Source.
